| 前收市價 | 2.7500 |
| 開市 | 2.4500 |
| 買盤 | 2.6000 |
| 賣出價 | 2.8000 |
| 拍板 | 85.00 |
| 到期日 | 2024-08-16 |
| 今日波幅 | 2.4500 - 2.5200 |
| 合同範圍 | 無 |
| 成交量 | |
| 未平倉合約 | 644 |
ZacksHOLX or EW: Which Is the Better Value Stock Right Now?
HOLX vs. EW: Which Stock Is the Better Value Option?
ZacksHere's Why You Should Retain Edward Lifesciences (EW) for Now
Investors are optimistic about Edward Lifesciences (EW), led by the strong performance of its SAPIEN 3 Ultra RESILIA platform and strong solvency.
BenzingaIndian Rival Meril Accuses Edwards Lifesciences Of Anti-Competitive Behavior In EU Antitrust Complaint
On Monday, U.S. heart valve manufacturer Edwards Lifesciences Corporation (NYSE:EW) faced an EU antitrust complaint from Indian competitor Meril, alleging anti-competitive behavior, particularly concerning patents. This could potentially intensify EU regulators’ scrutiny of Edwards, Reuters reports. Recent regulatory actions in the United States and Europe aim to promote fair competition and maintain drug and product affordability, especially for smaller innovative companies challenging larger i
